Activated PPARγ Abrogates Misprocessing of Amyloid Precursor Protein, Tau Missorting and Synaptotoxicity

Type 2 diabetes increases the risk for dementia, including Alzheimer’s disease (AD). Pioglitazone (Pio), a pharmacological agonist of the peroxisome proliferator-activated receptor γ (PPARγ), improves insulin sensitivity and has been suggested to have potential in the management of AD symptoms, albe...

Descripción completa

Detalles Bibliográficos
Autores principales: Moosecker, Susanne, Gomes, Patrícia, Dioli, Chrysoula, Yu, Shuang, Sotiropoulos, Ioannis, Almeida, Osborne F. X.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584807/
https://www.ncbi.nlm.nih.gov/pubmed/31263400
http://dx.doi.org/10.3389/fncel.2019.00239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584807/
https://www.ncbi.nlm.nih.gov/pubmed/31263400
http://dx.doi.org/10.3389/fncel.2019.00239

Ejemplares similares